Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex
Pedro M Folegatti1, Amy Flaxman1, Daniel Jenkin1
1The Jenner Institute, University of Oxford, Oxford OX3 7DQ, UK.
Abstract:
Heterologous prime-boost strategies are known to substantially increase immune responses in viral vectored vaccines. Here we report on safety and immunogenicity of the poxvirus Modified Vaccinia Ankara (MVA) vectored vaccine expressing four Mycobacterium avium subspecies paratuberculosis antigens as a single dose or as a booster vaccine following a simian adenovirus (ChAdOx2) prime. We demonstrate that a heterologous prime-boost schedule is well tolerated and induced T-cell immune responses.
Insights
A prime-boost vaccine strategy using Modified Vaccinia Ankara (MVA) and a simian adenovirus vector showed good safety and induced T-cell immune responses against Mycobacterium avium subspecies paratuberculosis.
Area of Science:
- Vaccinology
- Immunology
- Infectious Diseases
Background:
- Heterologous prime-boost vaccination strategies enhance immune responses in viral vectored vaccines.
- Mycobacterium avium subspecies paratuberculosis (MAP) causes Johne's disease in ruminants, posing economic challenges to the livestock industry.
Purpose of the Study:
- To evaluate the safety and immunogenicity of a Modified Vaccinia Ankara (MVA) vectored vaccine expressing four MAP antigens.
- To assess the vaccine's efficacy as a single dose or as a booster following a simian adenovirus (ChAdOx2) prime.
Main Methods:
- The study involved administering a poxvirus MVA vectored vaccine, either alone or after a ChAdOx2 prime.
- Safety and T-cell immune responses were monitored in the vaccinated subjects.
Main Results:
- The heterologous prime-boost schedule using ChAdOx2 followed by MVA was well tolerated.
- This prime-boost approach successfully induced significant T-cell immune responses.
Conclusions:
- A heterologous prime-boost vaccination strategy with ChAdOx2 and MVA is safe and effective in eliciting T-cell immunity.
- This approach holds promise for developing vaccines against Mycobacterium avium subspecies paratuberculosis.
More Related Videos
Related Concept Videos
Vaccinations
Microorganisms in Medicine and Therapeutics


